Nucleic acid testing for transfusion-transmissible agents

Current Opinion in Hematology

Volumn 7, Issue 6, 2000, Pages 387-391

  Stramer, Susan L ^a  

^a National Confirmatory Testing Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

BLOOD DONOR; BLOOD TRANSFUSION; GENETIC ANALYSIS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RNA ANALYSIS; SEROCONVERSION; SERODIAGNOSIS; UNITED STATES; VIRUS INFECTION;

BLOOD TRANSFUSION; HEPATITIS C; HIV; HUMANS; MASS SCREENING; RNA, VIRAL; VIRUS DISEASES;

EID: 0033792914     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200011000-00011     Document Type: Review

References (22)

1. Evolving applications of nucleic acid amplification assays for prevention of virus transmission by blood components and derivatives
2. Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors: Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases
3. High throughput assay for simultaneous or separate detection of human immunodeficiency virus (HIV) and hepatitis type C virus (HCV)
4. Blood screening by mucleic acid amplification technology: Current issues, future challenges
5. Stability of HCV RNA for pooled genome amplification testing (GAT)
6. The risk of transfusion-transmitted viral infections
7. Sensitivity of HIV and HCV RNA detection by pooled genome amplication testing (GAT)
8. HIV, HBV and HCV: New developments related to transfusion safety
9. Comparison of four seroconverting bood donors identified by HIV-1 p24 antigen (Ag) screening
10. Replacement of HIV-1 p24 antigen screening with HIV-1 RNA nucleic acid testing (NAT) for whole blood donations
11. Redefining the HIV-1 infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission
12. Hepatitis C virus transmission by a blood donation negative in nucliec acid amplification tests for viral RNA
13. Prolonged antibody-negative HCV viremia in a US blood donor with apparent HCV transmission to a recipient
14. Identification of recent risk factors among blood donors confirmed to be HCT NAT reactive, anti-HVC non-reactive
15. NAT of the United States and Canadian blood supply
16. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation
17. Failure of routine HIV-1 tests in a case involving transmission wiuth pre-seroconversion blood components during the infectious window period
18. HIV viremia preceding antibody (Ab) seroconversion (SC): Detection by p24 Antigen (Ag), minipool nucleic acid amplification tests (MP-NAT) and individual donation (ID) NAT
19. Dynamics of HCV viremia during early HCV infection: Implications from minipool (MP) vs individual donation (ID) nucleic acid amplification testing (NAT)
20. HBV viremia preceding HBsAg positivity: Implementations for minipool (MP) and individual donation (ID) HBV nucleic acid testing (NAT)
21. Detection of hepatitis B seroconversion by highly sensitive assays for surface antigen and HBV DNA